Trulieve Cannabis (TRLV) Gains from Investment Securities (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Gains from Investment Securities for 7 consecutive years, with $14.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 175.59% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $10.5 million (up 179.84% YoY), while the FY2025 annual figure was $1.5 million, up 108.01% from the prior year.
• Gains from Investment Securities came in at $14.1 million for Q1 2026 at Trulieve Cannabis, up from $969000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $102.8 million in Q3 2023, with the low at -$98.9 million in Q4 2023.
• Average Gains from Investment Securities over 5 years is $96660.8, with a median of $227995.5 recorded in 2022.
• Across the five-year window, Gains from Investment Securities soared 5015.83% in 2023 and sank 3376.26% in 2024, its largest moves.
• Year by year, Gains from Investment Securities stood at -$4.0 million in 2022, then tumbled by 2356.25% to -$98.9 million in 2023, then jumped by 80.32% to -$19.5 million in 2024, then jumped by 104.98% to $969000.0 in 2025, then soared by 1357.59% to $14.1 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $14.1 million, $969000.0, and $97000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.